This inventor holds 5 USPTO granted patents. Top assignees: Cv Molecular Therapeutics, Inc., Simon W. Rabkin, Other. Active years: 1997-2006.
Company Filing History:
3 out of 3 
1 out of 1 
1 out of 834,307 Years Active: 1997-2006
Title: Simon W. Rabkin: Innovator in Peptide Research
Introduction
Simon W. Rabkin is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of peptide research, particularly in the context of reducing cell death associated with various diseases. With a total of 5 patents to his name, Rabkin's work has the potential to impact therapeutic approaches in medicine.
Latest Patents
Rabkin's latest patents focus on innovative methods involving peptides. One of his notable inventions is a method to reduce cell death in warm-blooded animals, particularly in cases associated with neurodegenerative disorders, immune diseases, neoplastic disorders, inflammatory disorders, or viral diseases. This method involves administering a therapeutically effective amount of a peptide with the amino acid sequence: Ser-Val-Asp-Val-Glu-Tyr. Additionally, he has disclosed novel peptides, fragments, or analogues obtained from streptokinase, which are suitable for use in ameliorating cell death and related methods.
Career Highlights
Throughout his career, Simon W. Rabkin has worked with various organizations, including Cv Molecular Therapeutics, Inc. and his own venture, Simon W. Rabkin. His research has been instrumental in advancing the understanding of peptide applications in medical science.
Collaborations
Rabkin has collaborated with notable professionals in his field, including Gerald Krystal, enhancing the impact of his research through shared expertise.
Conclusion
Simon W. Rabkin's contributions to peptide research exemplify the innovative spirit of modern science. His work continues to pave the way for new therapeutic methods that could significantly improve patient outcomes.